Your browser doesn't support javascript.
loading
Association of Apolipoprotein E (APOE) Polymorphisms With Serological Lipid and Inflammatory Markers.
Krishnamurthy, Hari K; Rajavelu, Imbaasree; Reddy, Swarnkumar; Pereira, Michelle; Jayaraman, Vasanth; Krishna, Karthik; Song, Qi; Wang, Tianhao; Bei, Kang; Rajasekaran, John J.
Afiliação
  • Krishnamurthy HK; Biomedical Engineering, Vibrant Sciences LLC, San Carlos, USA.
  • Rajavelu I; Clinical Research, Vibrant America LLC, San Carlos, USA.
  • Reddy S; Clinical Research, Vibrant America LLC, San Carlos, USA.
  • Pereira M; Clinical Research, Vibrant America LLC, San Carlos, USA.
  • Jayaraman V; Research & Development, Vibrant Sciences LLC, San Carlos, USA.
  • Krishna K; Research & Development, Vibrant Sciences LLC, San Carlos, USA.
  • Song Q; Data Acquisition and Analysis, Vibrant America LLC, San Carlos, USA.
  • Wang T; Data Acquisition and Analysis, Vibrant Sciences LLC, San Carlos, USA.
  • Bei K; Data Acquisition and Analysis, Vibrant Sciences LLC, San Carlos, USA.
  • Rajasekaran JJ; Research & Development, Vibrant Sciences LLC, San Carlos, USA.
Cureus ; 16(5): e60721, 2024 May.
Article em En | MEDLINE | ID: mdl-38903305
ABSTRACT
Background  The study aims to assess the association of apolipoprotein E (APOE) gene polymorphisms with serological lipid and inflammatory markers to determine their potential role in predicting the risk of cardiovascular diseases (CVDs) and Alzheimer's disease (AD).  Methodology  A total of 915 individuals underwent testing for lipid and inflammatory biomarkers at Vibrant America Clinical Laboratory. Clinical data, blood lipid and inflammatory profiles, and APOE genotyping were analyzed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).  Results Compared to the E3/E3 genotype, individuals with E2/E3 genotypes showed higher levels of high-density lipoprotein (HDL), triglycerides, apolipoprotein A (APOA), high-sensitivity C-reactive protein (hs-CRP), and myeloperoxidase (MPO). E2/E4 genotype carriers had higher levels of HDL, triglycerides, Lp(a), and N-terminal pro b-type natriuretic peptide (BNPNT). E3/E4 genotypes were associated with elevated levels of total cholesterol, LDL, Lp(a), hs-CRP, small-density low-density lipoprotein (SDLDL), oxidized LDL (OXLDL), MPO, LDL-CAL, PLAC, and APOB. The E4/E4 group displayed higher concentrations of total cholesterol, LDL, APOB, Lp(a), hs-CRP, SDLDL, OXLDL, MPO, LDLCAL, and PLAC compared to E3/E3 carriers. These findings highlight the potential atherogenic effect of the ε4 allele and the protective effect of the ε2 allele based on lipid and inflammatory marker profiles.  Conclusions This study provides strong evidence linking APOE gene polymorphism to abnormal serum lipid and inflammatory profiles. Individuals carrying the ε4 alleles exhibited dysregulated lipid metabolism and abnormal inflammatory markers, increasing their risk of CVD and AD. Early detection and prompt diagnosis are crucial for implementing therapeutic, dietary, and lifestyle interventions to mitigate risks and prevent or delay lipid and inflammation-related disorders.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article